Physicists at the University of Oxford have contributed to a new study which has found that iron-rich asteroids can tolerate ...

Buildroid says its block-laying robot and supporting mobile robots, validated in simulation, can automate 80% of masonry work ...

Structure Therapeutics (GPCR) just moved its obesity pipeline up a gear by kicking off a first in human Phase 1 trial for ACCG-2671, its oral amylin receptor agonist targeting metabolic disease. See ...

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs ...

Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 Healthcare dealmakers are heading to San Francisco this weekend betting on a new wave of mega-mergers in 2026 that could ...

When is the Paralives release date? This upcoming life sim has caught a reputation as the next big Sims rival, and it's easy to see why. With cute outfits, tons of items, an extensive character ...